Bangladesh Pharmaceuticals and Healthcare Report

1
Bangladesh Pharmaceuticals and Healthcare
Report
2
Summary
The Bangladesh Pharmaceuticals Healthcare
Report features BMI Research's forecasts for
drugs and healthcare expenditure and imports and
exports, focusing on the growth outlook for the
prescription, OTC, patented drugs and generics
market segments. BMI's Bangladesh
Pharmaceuticals Healthcare Report provides
industry professionals, strategists, company
executives, investors, analysts and
sales/marketing heads with independent forecasts
and competitive intelligence on the Bangladesh
pharmaceutical and healthcare industry.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
3
Key Benefits-Benchmark BMI's pharmaceutical and
healthcare market forecasts for Bangladesh, to
test other views - a key input for successful
budgeting and strategic business planning in the
Bangladeshi pharmaceutical and healthcare
market.-Target business opportunities and risks
in the Bangladeshi pharmaceutical and healthcare
sector through our reviews of latest industry
trends, regulatory changes and major deals,
projects and investments in Bangladesh.-Assess
the activities, strategy and market position of
your competitors using our company profiles
(including SWOTs, KPIs and latest activity) and
competitive landscape tables.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
4
CoverageIndustry ViewAn at-a-glance
perspective on the latest regulatory
developments, key forecast indicators and major
corporate developments, covering the
prescription, OTC and generics markets. The
pharmaceuticals and healthcare SWOT outlines
strategic factors that affect the basic
assumptions underpinning BMIs forecast analysis,
and taken together with BMIs political, economic
and business environment SWOTs, it gives a
complete overview of market climate.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
5
Industry Forecast Scenario-Industry forecasts
to end-2019 for all key indicators, supported by
explicit assumptions, plus analysis of key
downside risks to the main forecasts-Healthcare
Total healthcare expenditure (USDbn), healthcare
expenditure ( of GDP), healthcare expenditure
per capita (USD), hospital beds, doctors, and
birth mortality rates (all per 000
population).-Pharmaceutical Market Drug
expenditure in USDbn, of GDP and per capita
(USD).-Patented Drug Market Prescription drug
sales (USDbn of total sales).-Generic Drug
Market Generic product sales (USDbn), generic
sales ( of total sales).-OTC Drug Market OTC
sales (USDbn of total sales).
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
6
Macroeconomic Forecasts Nominal and real GDP,
real GDP growth, private consumption growth,
industrial output growth, consumer price index,
GDP price deflator, exports, imports, trade
balance, current account balance, foreign direct
investment, exchange rate against USD, government
expenditure and external debt.Pharmaceuticals
and Healthcare Risk Reward IndexIt provides
investors (both national and multinational)
looking for opportunities in the region with a
clear country-comparative assessment of the
markets risks and potential rewards. Each of the
country markets are scored using a sophisticated
model that includes more than 40 industry,
economic and demographic data points to provide
indices of highest to lowest appeal to investors,
with each position explained.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
7
Market SummaryA snapshot of key market
characteristics, including total size of the
pharmaceuticals and healthcare segments, growth
drivers, leading therapeutic areas and the
competitive landscapeIndustry DevelopmentsA
focus on government healthcare reforms,
epidemiological trends, mergers and acquisitions,
product launches, market entries, FDI activity,
RD, biotechnology, clinical trials and supply
chain issues.Regulatory RegimeDetails of the
industry regulatory framework and key legislation
covering the licensing of new products/services,
pricing and reimbursements, intellectual
property, taxation and advertising, as well as
analysis of the overall regulatory burden.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
8
Competitive LandscapeThe competitive landscape
section provides comparative company analyses and
index by USD sales and share of total sales
for the total pharmaceutical sector, as well as
the OTC, generics and distribution
sub-sectors.Company ProfilesExamines the
competitive positioning and short- to medium-term
business strategies of key industry players.
Strategy is examined within the context of BMIs
industry forecasts, our macroeconomic views and
our understanding of the wider competitive
landscape to generate Company SWOT analyses. The
latest financial and operating statistics and key
company developments are also incorporated within
the company profiles, enabling a full evaluation
of recent company performance and future growth
prospects.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
9
Table of Contents
Industry ViewSWOTPoliticalEconomicBusiness
EnvironmentIndustry ForecastPharmaceutical
Market ForecastTable Pharmaceutical Sales,
Historical Data And ForecastsHealthcare Market
ForecastTable Healthcare Expenditure Trends,
Historical Data And ForecastsTable Government
Healthcare Expenditure Trends, Historical Data
And Forecasts
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
10
To view the full Executive Summary and Table of
Contents, please visit Bangladesh
Pharmaceuticals and Healthcare ReportContact
Us-Call India 91-22-27810772/73Email id
info_at_bharatbook.com Website www.bharatbook.com
Our Blog https//www.bharatbook.com/blog/

Follow Us On